Revamped South African National AIDS Council begins work reviewing national plan

South Africa "recently unveiled" a "newly reformed" South African National AIDS Council (SANAC), "coinciding with the announcement that the country has achieved universal access to HIV treatment," PlusNews reports. Responding to a 2010 review of the body, SANAC "will now hold a new, annual meeting comprised of representatives from the research community, labor unions and people living with HIV," at which "participants will discuss major policy issues and review progress on the country's current national plan to address the twin epidemics of HIV and tuberculosis," according to the news service.

At a recent meeting, "SANAC announced new figures showing that two million South Africans are now on antiretrovirals; this figure covers about 80 percent of those estimated to need treatment in the country, surpassing the country's 2006 universal access target, according to a UNAIDS report," PlusNews writes, noting the country "must now ramp-up prevention, new SANAC CEO Fareed Abdullah said." South African Deputy President Kgalema Motlanthe, who chairs SANAC, said the body would be strengthening "Provincial Councils on AIDS to better monitor the provincial responses," the news service states (10/9).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research suggests no need for yellow fever vaccine booster after initial dose